Table 2.
Share of remaining life expectancy taking specific classes of prescription drugs at ages 0, 25, 45, 65, and 85 for men and women in 1996 and 2019: Percentages
| Age 0 |
Age 25 |
Age 45 |
Age 65 |
Age 85 |
||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Men | 1996 | 2019 | 1996 | 2019 | 1996 | 2019 | 1996 | 2019 | 1996 | 2019 |
| Cardiometabolic Agents | 21 | 31 | 31 | 44 | 46 | 63 | 61 | 82 | 58 | 80 |
| Cardiovascular agents | 9 | 10 | 14 | 14 | 21 | 21 | 35 | 32 | 42 | 38 |
| Antihypertensives | 14 | 22 | 21 | 33 | 31 | 48 | 43 | 66 | 39 | 65 |
| Metabolic agents | 6 | 12 | 9 | 17 | 14 | 25 | 19 | 33 | 21 | 33 |
| Statins | 3 | 16 | 5 | 24 | 7 | 37 | 8 | 51 | 0 | 52 |
| Psychotherapeutic (total) | 13 | 18 | 15 | 21 | 18 | 25 | 25 | 31 | 37 | 34 |
| CNS agents | 10 | 14 | 12 | 16 | 14 | 20 | 19 | 24 | 26 | 23 |
| Psychotherapeutic agents | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 1 |
| Antidepressants | 4 | 7 | 5 | 9 | 6 | 11 | 8 | 12 | 9 | 13 |
| Antipsychotics | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 2 | 3 | 3 |
| Hormones/Hormone Modifiers | 6 | 9 | 8 | 12 | 10 | 17 | 14 | 24 | 17 | 35 |
| Coagulation Modifiers | 3 | 5 | 4 | 8 | 7 | 12 | 12 | 21 | 14 | 30 |
| Gastrointestinal Agents | 8 | 9 | 11 | 12 | 15 | 17 | 20 | 22 | 21 | 19 |
| Anti-infectives | 28 | 18 | 26 | 19 | 29 | 21 | 33 | 24 | 24 | 20 |
| Respiratory Agents | 16 | 10 | 15 | 10 | 18 | 13 | 19 | 16 | 16 | 18 |
| Non-opioid Analgesics | 12 | 9 | 15 | 11 | 18 | 13 | 18 | 14 | 10 | 13 |
| Opioids | 8 | 7 | 10 | 9 | 11 | 11 | 12 | 12 | 17 | 7 |
| Topical Agents | 20 | 12 | 21 | 14 | 24 | 18 | 33 | 25 | 33 | 26 |
| Nutritional Products | 4 | 4 | 5 | 6 | 7 | 9 | 12 | 13 | 14 | 12 |
| Genitourinary Tract Agents | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 3 | 3 | 2 |
| Biologicals and Immunologic Agents | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 2 | 0 | 2 |
| Antineoplastics | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 0 | 1 |
| Alternative Medicines | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 1 |
| Miscellaneous | 0 | 2 | 1 | 3 | 1 | 3 | 1 | 3 | 0 | 2 |
|
| ||||||||||
| Age 0 |
Age 25 |
Age 45 |
Age 65 |
Age 85 |
||||||
| Women | 1996 | 2019 | 1996 | 2019 | 1996 | 2019 | 1996 | 2019 | 1996 | 2019 |
|
| ||||||||||
| Cardiometabolic Agents | 25 | 32 | 35 | 44 | 50 | 60 | 66 | 78 | 78 | 88 |
| Cardiovascular agents | 10 | 6 | 15 | 8 | 21 | 11 | 32 | 16 | 45 | 21 |
| Antihypertensives | 18 | 24 | 26 | 34 | 37 | 48 | 51 | 66 | 60 | 80 |
| Metabolic agents | 6 | 11 | 9 | 15 | 13 | 21 | 18 | 27 | 15 | 25 |
| Statins | 3 | 15 | 4 | 21 | 7 | 31 | 8 | 44 | 3 | 44 |
| Psychotherapeutic (total) | 19 | 27 | 24 | 34 | 27 | 39 | 29 | 42 | 28 | 39 |
| CNS agents | 14 | 19 | 17 | 25 | 20 | 28 | 21 | 32 | 20 | 30 |
| Psychotherapeutic agents | 2 | 1 | 2 | 1 | 2 | 1 | 2 | 0 | 1 | 0 |
| Antidepressants | 7 | 15 | 10 | 20 | 10 | 22 | 10 | 24 | 10 | 22 |
| Antipsychotics | 1 | 2 | 1 | 2 | 1 | 2 | 2 | 2 | 3 | 1 |
| Hormones/Hormone Modifiers | 20 | 17 | 28 | 23 | 38 | 29 | 32 | 32 | 24 | 29 |
| Coagulation Modifiers | 2 | 4 | 3 | 6 | 5 | 9 | 9 | 15 | 11 | 21 |
| Gastrointestinal Agents | 9 | 13 | 13 | 17 | 16 | 23 | 20 | 29 | 18 | 33 |
| Anti-infectives | 34 | 25 | 33 | 26 | 32 | 28 | 30 | 29 | 28 | 25 |
| Respiratory Agents | 20 | 14 | 22 | 15 | 23 | 18 | 20 | 19 | 12 | 18 |
| Non-opioid Analgesics | 16 | 13 | 20 | 16 | 22 | 18 | 21 | 17 | 22 | 18 |
| Opioids | 12 | 10 | 15 | 13 | 15 | 15 | 16 | 18 | 18 | 22 |
| Topical Agents | 25 | 17 | 27 | 20 | 30 | 24 | 32 | 30 | 35 | 31 |
| Nutritional Products | 9 | 8 | 10 | 10 | 11 | 13 | 16 | 17 | 22 | 22 |
| Genitourinary Tract Agents | 1 | 2 | 2 | 3 | 2 | 4 | 2 | 6 | 1 | 6 |
| Biologicals and Immunologic Agents | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 0 |
| Antineoplastics | 5 | 2 | 7 | 3 | 9 | 3 | 6 | 4 | 3 | 3 |
| Alternative Medicines | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 2 | 0 | 5 |
| Miscellaneous | 1 | 3 | 1 | 4 | 1 | 4 | 1 | 3 | 1 | 2 |
Note: Main (nonindented) categories are mutually exclusive and exhaustive.
Source: Data are from the author’s calculations based on the MEPS and the HMD, 1996 and 2019.